Health
BIOCAD to produce liquid vaccine for COVID-19 treatment – News-Medical.Net
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a n…
Reviewed by Emily Henderson, B.Sc.Sep 25 2020
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a new adenovirus.
This is done in order to exclude the presence of neutralizing antibodies against the vaccine in humans and thus enhance the reliability of repeated injection. The article on …
-
General22 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General21 hours agoJaguar Land Rover in UK pauses shipments to US
-
General19 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General17 hours agoAustralian share market set to dive as threat of US recession grows